Breaking News

Bayer Invests $150M to Build Cell Culture Technology Center

New, 40,000 sq.-ft. facility in Berkeley, CA will support the development of emerging therapies in Bayer's biologics portfolio

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bayer is investing $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center for the development of biological therapies. The new 40,000 square foot facility, which is expected to be ready for clinical production in late 2021, will support the development of emerging therapies in Bayer’s portfolio with an emphasis on oncology, cardiology and additional specialty care therapeutic areas. Bayer has selected Fluor for design...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters